Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pediatric Bioscience was a biotechnology company focused on developing diagnostic tools for the early detection and risk assessment of Autism Spectrum Disorder (ASD). The company's primary technology centered on Maternal Autoantibody-Related Autism (MARA), identifying specific patterns of maternal autoantibodies that react with fetal brain proteins. By detecting these biomarkers in a mother's blood, the company aimed to provide a risk assessment for ASD before or during pregnancy. Headquartered in San Diego, the company collaborated closely with researchers at the UC Davis MIND Institute. Although the company is no longer active, its research into the maternal immune system's role in neurodevelopment has significantly influenced the field of autism diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pediatric Bioscience.